Cargando…
Combination of serum 5-S-cysteinyldopa, melanoma inhibitory activity and IL-8 improves the diagnostic accuracy of malignant melanoma compared with individual markers
Early diagnosis of malignant melanoma is critical for effective treatment and reduced patient mortality. However, current clinical and histological variables show limited accuracy in diagnosis. Serum or urine level of 5-S-cysteinyldopa (5-S-CD) is a commonly used melanoma biomarker in Japan owing to...
Autores principales: | Katoh, Yuki, Hara, Hiroyuki, Harada, Tomonori, Hirai, Shuichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439753/ https://www.ncbi.nlm.nih.gov/pubmed/36107519 http://dx.doi.org/10.1097/MD.0000000000030471 |
Ejemplares similares
-
Significance of 5-S-Cysteinyldopa as a Marker for Melanoma
por: Wakamatsu, Kazumasa, et al.
Publicado: (2020) -
Malignant melanoma of the male urethra with increased 5‐S‐cysteinyldopa: A case report
por: Aoki, Yusuke, et al.
Publicado: (2019) -
Determination of 5-S-cysteinyldopa in melanomas with a fluorimetric method.
por: Rorsman, H., et al.
Publicado: (1973) -
Clinical value of Melanoma Inhibitory Activity in stratifying malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015) -
Melanoma Inhibitory Activity and regional lymph node status in malignant melanoma patients
por: Sandru, Angela, et al.
Publicado: (2015)